Junction Bioscience
ActiveAI Hypothesis Engine for Molecular Discovery
About
Junction Bioscience is building an autonomous AI scientist to navigate the discovery of transformative medicines. Our scientific hypothesis engine iterates upon breakthrough chemistry from the laboratory to achieve clarity and control over the molecular basis of disease. We focus on the intersection of neuroinflammation and immunology where uncommon molecular insights position us to develop best-in-class therapies for millions of patients in need.
Founders · 1
Brian is a theoretical physicist and drug hunter with degrees in mathematics and chemistry from Duke University and doctoral training from NYU. He was previously the first employee and Vice President at a computational drug design startup where he led the Machine Learning operation and grew a 30-person team to success on previously-undruggable targets.
Launch
Our lab-in-the-loop protein copilot rapidly iterates upon hypotheses to design better medicines
Junction Bioscience building an autonomous hypothesis engine to design and test drug candidates by translating atomic-level chemistry into cellular effects, focusing on neuroinflammation and immunology. They announce early partnerships and openness to collaborations to advance their internal therapeutics pipeline and autonomous AI-driven discovery platform.
From the original launch (Mar 2024) — may be outdated.
Related startups
Gen AI molecular simulations that reproduce wetlab results
"If-then" conditional logic for protein drugs
